Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B-Reference-Cited by-同舟云学术

Bevacizumab plus chemotherapy in nonsquamous non‐small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B

Published:2020-05-18 Issue:7 Volume:11 Page:1876-1884
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Noro Rintaro¹^ORCID,Kobayashi Kunihiko²,Usuki Jiro³,Yomota Makiko⁴,Nishitsuji Masaru⁵,Shimokawa Tsuneo⁶,Ando Masahiro⁷,Hino Mitsunori⁸,Hagiwara Koichi⁹,Miyanaga Akihiko¹,Seike Masahiro¹,Kubota Kaoru¹,Gemma Akihiko¹,

Affiliation:

1. Department of Pulmonary Medicine and OncologyGraduate School of Medicine, Nippon Medical School Tokyo Japan

2. Department of Respiratory medicineSaitama Medical University International Medical Center Saitama Japan

3. Department of Pulmonary MedicineNippon Medical School Musashikosugi Hospital Kawasaki Japan

4. Department of Thoracic Oncology and Respiratory MedicineTokyo Metropolitan Cancer and Infectious disease Center Komagome Hospital Tokyo Japan

5. Department of Respiratory MedicineIshikawa Prefectural Central Hospital Kanazawa Japan

6. Department of Respiratory Medicine and Medical OncologyYokohama Municipal Citizen's Hospital Yokohama Japan

7. Department of Internal MedicineJizankai Medical Foundation Tsuboi Cancer Center Hospital Fukushima Japan

8. Department of Pulmonary MedicineNippon Medical School Chiba Hokuso Hospital Chiba Japan

9. Division of Pulmonary MedicineJichi Medical University Tochigi Japan

Funder

Kyoto University

Saitama Medical University

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13472

Reference36 articles.

1. Pleural effusion

2. Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer

3. Malignant Pleural Effusions

4. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861

5. Important prognostic factors for survival in patients with malignant pleural effusion

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer;Clinical and Translational Medicine;2024-04

2. First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?;Investigational New Drugs;2024-02-22

3. First-line treatment for driver gene–negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab？;2023-09-27

4. Comparison between different treatment regimens of vascular targeting drug to malignant pleural effusion in patients with lung cancer: A Bayesian network meta-analysis;Medicine;2023-07-21

5. Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion;International Journal of Molecular Sciences;2023-02-02